PANAREA PARTNERS

THE BUSINESS NEED

Healthcare in growth markets remains attractive
despite recent challenges to local economies.

By 2016, the global pharmaceutical industry is expected to generate an estimated 30 percent of its total sales in emerging markets*

But these expectations will be met only if the industry moves toward more bespoke market strategies.

A comprehensive understanding and commitment to these highly significant but very diverse markets and local partners of excellence is therefore essential.

*SOURCE: Booz&Co. Pharma Emerging Markets 2.0. How Emerging Markets Are Driving the Transformation of the Pharmaceutical Industry, 2013